Skip to content
value.today

Cassava Sciences, Inc. vs Regenxbio Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Regenxbio Inc. is the larger company by market value: $513 M against $115 M for Cassava Sciences, Inc., 4.5 times as much (market caps of Aug 1, 2026 for Cassava Sciences, Inc. and Oct 6, 2026 for Regenxbio Inc.). Cassava Sciences, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • Both made a net loss: $76 M for Cassava Sciences, Inc. and $194 M for Regenxbio Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0421842126316832020202120222023202420252026Cassava Sciences, Inc. 101Regenxbio Inc. 35

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025Regenxbio Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCassava Sciences, Inc.
SAVA · #18,221 in the world
Regenxbio Inc.
RGNX · #12,415 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded1998—
Size
Market cap$115 M$513 M
Revenue$0 M$170 M
Net income$-76 M▲ best$-194 M
Employees—372
Valuation
Price to sales—3.3×
Price to book0.5×5.0×
Free cash flow yield—-24.6%
Profitability
Operating margin—-94.6%
Net margin—-113.8%
Return on equity—-107.0%
Growth
Revenue growth—104.5%
Revenue growth, 3 years a year—14.8%
Cash
Free cash flow margin—-74.1%
Altman Z-score zone—distress
Data as ofMarket cap Aug 2026Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Cassava Sciences, Inc. or Regenxbio Inc.?

Regenxbio Inc. is the larger company by market value: $513 M against $115 M for Cassava Sciences, Inc., 4.5 times as much (market caps of Aug 1, 2026 for Cassava Sciences, Inc. and Oct 6, 2026 for Regenxbio Inc.). Cassava Sciences, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, Cassava Sciences, Inc. or Regenxbio Inc.?

Both made a net loss: $76 M for Cassava Sciences, Inc. and $194 M for Regenxbio Inc.